Gelesis Holdings, Inc. Gelesis Holdings, Inc.

Gelesis Holdings, Inc.

GLS

Rangering i aksjer #40621
Gelesis Holdings Inc. is a biopharmaceutical company actively marketing... Gelesis Holdings Inc. is a biopharmaceutical company actively marketing products, dedicated to creating biomimetic solutions that target the underlying causes of obesity and chronic gastrointestinal conditions. Among its key offerings is PLENITY, an oral therapeutic designed for weight management that is non-stimulant and does not enter the bloodstream. The company also provides an additional product for individuals who are overweight or obese, and its robust pipeline features potential treatments for non-alcoholic fatty liver disease/non-alcoholic steatohepatitis, type 2 diabetes, and GS500 for Functional Constipation. Established in 2006, Gelesis Holdings Inc. operates from its headquarters in Boston, Massachusetts.
Aksjekurs
$0.0121
Sist synkronisert: 2023-05-23
Markedsverdi
$97.54K
Endring (1 dag)
-24.38%
Endring (1 år)
12,000.00%
Land
US
Handel Gelesis Holdings, Inc. (GLS)

Kategori

Healthcare
Historikk for aksjesplitt for Gelesis Holdings, Inc. (GLS)
Aksjen Gelesis Holdings, Inc. (symbol: GLS) har gjennomgått totalt 0 aksjesplitt.
Den nyeste splittelsen skjedde Oct 21, 2026.
Én GLS-aksje kjøpt før Oct 21, 2026 tilsvarer i dag 0 GLS-aksjer.
Liste over aksjesplitt
År Splitt Multiplikator Kumulativ multiplikator
Ikke nok data for de angitte datoene.
Aksjesplitt for lignende selskaper eller konkurrenter
Selskap Antall aksjesplitt Kumulativ multiplikator Land
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 1 x2
US
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 0 -
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
 1 x3
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 0 -
CH
Argenx SE Argenx SE
Argenx SE
ARGX.US
 0 -
NL